Medical Research And Development Funding companies

We invest in cancer innovation, together.

Investing in the future of medicine.

The Michigan Biomedical Venture Fund (MBVF) invests in and supports life science startup companies with U-M licensed intellectual property – including therapeut…

Accelerating life-extending therapies, treatments and cures for all myeloma patients.

Finchley Healthcare Ventures (FHCV) is a Canadian venture capital fund founded in 2022 specializing in investments within the rapidly evolving landscape of life…

The Cystic Fibrosis Foundation is a leading healthcare nonprofit organization like no other. For decades, we have been taking major steps and pioneering new way…

We're sophisticated managers of a life sciences venture capital fund.

Early-stage funding for European life sciences companies.

A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.

The JDRF T1D Fund is a venture philanthropy fund whose mission is to accelerate life-changing solutions to treat, prevent, and cure type 1 diabetes (T1D) throug…

Pivotal Life Sciences is a global healthcare investment firm that supports companies developing high impact therapeutics to address major unmet medical needs.

Innovation Partnerships brings experienced investors, entrepreneurs, and domain experts as well as access to translational research funding and investment capit…

Global Investments in compelling Biotech and Med-Tech discoveries.

Invested in breaking ‍through paralysis.

Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.

Mass General Brigham Ventures is an early-stage venture capital firm founded in 2008 to advance new life science technologies emerging from Mass General Brigham…

We partner with outstanding entrepreneurs who harness groundbreaking science & technology to transform healthcare.

HealthCap is a family of venture capital funds investing globally in life sciences.

A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.

A venture capital firm uniquely dedicated to the frontier of neuroscience.